Halozyme Therapeutics, Inc. HALO
NASDAQ · United States · Health Technology
$108.21-2.20 (-1.99%)
Market open· · USD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
Market open· · USD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
Momentum and volatility snapshot
| Average | Value | Price vs. average |
|---|---|---|
| 20-period average | $110.36 | -1.95% · below |
| 50-period average | $102.39 | +5.68% · above |
| 200-period average | $78.10 | +38.54% · above |
| Avg. volume (1Y) | 2.00M |
Total return, dividends included.
All indicators are computed from the last year of daily closes. Returns and volatility use the dividend-adjusted series; averages and highs/lows use the traded price. Not investment advice.